Knight Therapeutics Announces Launch of Minjuvi® (tafasitamab) in Mexico

Provided By GlobeNewswire

Last update: Mar 26, 2025

MONTREAL, March 26, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-US) specialty pharmaceutical company, announced today the launch of Minjuvi^® (tafasitamab) by its Mexican affiliate, Grupo Biotoscana de Especialidad S.A. de C.V.